We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Study to Test V930/V932 in Patients With Cancers Expressing Human Epidermal Growth Factor Receptor 2 (HER-2) and/or Carcinoembryonic Antigen (CEA)(V930-003)(COMPLETED)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00647114
Recruitment Status : Completed
First Posted : March 31, 2008
Last Update Posted : March 13, 2015
Information provided by:
Merck Sharp & Dohme Corp.